Mismatch negativity analysis in drug-resistant epileptic patients implanted with vagus nerve stimulator

Brain Research Bulletin

Volumn 73, Issue 1-3, 2007, Pages 81-85

  Borghetti, D ^a,b   Pizzanelli, C ^a   Maritato, P ^a   Fabbrini, M ^a   Jensen, S ^a   Iudice, A ^a   Murri, L ^a   Sartucci, F ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^c CNR   (Italy)

Author keywords

Epilepsy; Independent component analysis; Memory; Vagal nerve stimulation

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG RESISTANCE; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; IMPLANT; LATENT PERIOD; MALE; MOOD; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SHORT TERM MEMORY; VAGUS NERVE STIMULATION;

ADULT; AFFECT; ATTENTION; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; VAGUS NERVE;

EID: 34248139692     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.02.004     Document Type: Article

References (52)

1. Alfimova M.V., Uvarova L.G., and Trubnikov V.I. A method of evoked potentials in the study of cognitive processes in schizophrenia. Zh Nevrol Psikhiatr Im S S Korsakova 99 1 (1999) 62-68
2. Armitage R., Husain M., Hoffman R., and Rush A.J. The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report. J. Psychosom. Res. 54 5 (2003) 475-482
3. Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J. Clin. Neurophysiol. 18 5 (2000) 415-418
4. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioural state and state-dependent cognitive processes. Brain Res. Rev. 42 (2003) 33-84
5. Brazdil M., Chadim P., Daniel P., Kuba R., Rektor I., Novak Z., and Chrastina J. Effect of vagal nerve stimulation on auditory and visual event-related potentials. Eur. J. Neurol. 8 5 (2001) 457-461
6. Carli M., Robbins T.W., Evenden J.L., and Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Res. 9 (1983) 361-380
7. Carpenter L.L., Friehs G.M., and Price L.H. Cervical vagus nerve stimulation for treatment-resistant depression. Neurosurg. Clin. N. Am. 14 2 (2003) 275-282
8. Ceponiene R., Kushnerenko E., Fellman V., Renlund M., Suominen K., and Näätänen R. Event-related potential features indexing central auditory discrimination by newborns. Cogn. Brain Res. 13 1 (2002) 101-113
9. Ceponiene R., Rinne T., and Näätänen R. Maturation of cortical sound processing as indexed by event-related potentials. Clin. Neurophysiol. 113 (2002) 870-882
10. Cheour M., Kushnerenko E., Ceponiene R., Fellman V., and Näätänen R. Electric brain responses obtained from newborn infants to changes in duration in complex harmonic tones. Dev. Neuropsychol. 22 2 (2002) 471-479
11. Cheour M., Shestakova A., Alku P., Ceponiene R., and Näätänen R. Mismatch negativity shows that 3-6-year-old children can learn to discriminate non native speech sounds within two months. Neurosci. Lett. 325 3 (2002) 187-190
12. Cheour-Lunthanen M., Alho K., Sainio K., Rinnie T., Reinkainen K., Pohjavuori M., Renlund M., Aaltonen O., Eerola O., and Näätänen R. The ontogenetically earliest discriminative response of the human brain. Psychophysiology 33 (1996) 478-481
13. Clarke B.M., Upton A.R., Griffin H., Fitzpatrick D., and DeNardis M. Chronic stimulation of the left vagus nerve: cognitive motor effects. Can. J. Neurol. Sci. 24 3 (1997) 226-229
14. Dodrill C.B., and Morris G.L. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav. 2 1 (2001) 46-53
15. Dorr A.E., and Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther. 318 2 (2006) 890-898
16. FineSmith R.B., Zampella E., and Devinsky O. Vagal nerve stimulator: a new approach to medically refractory epilepsy. N. J. Med. 96 6 (1999) 37-40
17. Foote S.L., Bloom F.E., and Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63 (1983) 844-914
18. Galli R., Bonanni E., Pizzanelli C., Maestri M., Lutzemberger L., Giorgi F.S., Iudice A., and Murri L. Daytime vigilance and quality of life in epileptic patients treated with vagus nerve stimulation. Epilepsy Behav. 4 2 (2003) 185-191
19. Heinze H.J., Munte T.F., Kutas M., Butler S.R., Näätänen R., Nuwer M.R., and Goodin D.S. Cognitive event-related potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr. Clin. Neurophysiol. Suppl. 52 (1999) 91-95
20. Holmes P.H., and Crawley J.N. Coexisting neurotransmitters in central noradrenergic neurons. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York 347-353
21. Hoppe C., Helmstaedter C., Scherrmann J., and Elger C.E. No evidence for cognitive side effects after 6 months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav. 2 4 (2001) 351-356
22. Javitt D.C., Grochowski S., Shelley A.M., and Ritter W. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalogr. Clin. Neurophysiol. Suppl. 108 2 (1998) 143-153
23. Kamisaki Y., Hamahashi T., Hamada T., Maeda K., and Itoh T. Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions. Eur. J. Pharmacol. 217 1 (1992) 57-63
24. Kosel M., and Schlaepfer T.E. Beyond the treatment of epilepsy: new applications of vagus nerve stimulation in psychiatry. CNS Spectr. 8 7 (2003) 515-521
25. Krahl S.E., Clark K.B., Smith D.C., and Browning R.A. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39 7 (1998) 709-714
26. Kraus N., McGee T., Sharma A., Carrell T., and Nicol T. Mismatch negativity event-related potential elicited by speech stimuli. Ear Hearing 13 (1992) 158-164
27. Kujala T., and Näätänen R. The mismatch negativity in evaluating central auditory dysfunction in dyslexia. Neurosci. Biobehav. Rev. 25 6 (2001) 535-543
28. Kushnarenko E., Ceponiene R., Balan P., Fellman V., Huotilainen M., and Näätänen R. Maturation of the auditory event-related potentials during the first year of life. Neurosci. Neuropsychol. 13 1 (2002) 47-51
29. Landre E. Vagus nerve stimulation and refractory partial epilepsies. Rev. Neurol. (Paris) 160 Spec. no. 1 (2004) 280-287
30. Long F., Wu X., and Fan L. Eliminating artifacts of EEG data based on independent component analysis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20 3 (2003) 479-483
31. McCarley R.W., Hsiao J.K., Freedman R., Pfefferbaum A., and Donchin E. Neuroimaging and the cognitive neuroscience of schizophrenia. Schizophr. Bull. 22 4 (1997) 703-725
32. McIntyre D.C., and Giugno L. Effect of clonidine on amygdala kindling in normal and 6-hydroxydopamine-pretreated rats. Exp. Neurol. 99 1 (1988) 96-106
33. Mehta M.A., Sahakian B.J., and Robbins T.W. Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals. In: Solanto M.V., Arnsten A.F.T., and Castellanos F.X. (Eds). Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (2001), Oxford University Press, New York 303-331
34. Michie P.T., Budd T.W., Todd J., Rock D., Wichmann H., Box J., and Jablensky A.V. Duration and frequency mismatch negativity in schizophrenia. Clin. Neurophysiol. 111 6 (2000) 1054-1065
35. Näätänen R. The mismatch negativity: a powerful tool for cognitive neuroscience. Ear Hearing 16 (1995) 6-18
36. Näätänen R. The mismatch negativity as an index of the perception of speech sounds by the human brain. Ross Fiziol Zh Im I M Sechenova 86 11 (2000) 1481-1501
37. Näätänen R., and Alho K. Mismatch negativity-a unique measure of sensory processing in audition. Int. J. Neurosci. 80 1-4 (1995) 317-337
38. Näätänen R., Gaillard A.W., and Mantysalo S. Early selective-attention effect on evoked potential reinterpreted. Acta Psychol. (Amst.) 42 4 (1978) 313-329
39. N'guyen S., and Pereon Y. Epidemiology of drug-resistant epilepsy. Rev. Neurol. (Paris) 160 Spec. no. 1 (2004) 31-35
40. Pekkonen E., Hirvonen J., Ahveninen J., Kählönen S., Kaakkola S., Huttunen J., and Jääskeläinen P. Memory-based comparison process not attenuated by haloperidol: a combined MEG and EEG study. Neuroreport 13 (2002) 177-181
41. Pekkonen E., Hirvonen J., Jääskeläinen I.P., Kaakkola S., and Huttunen J. Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease. Neuroimage 14 (2001) 376-382
42. Pekkonen E., Huotilainen M., Virtanen J., Näätänen R., Ilmoniemi R.J., and Erkinjuntti T. Alzheimer's disease affects parallel processing between the auditory cortices. Neuroreport 7 8 (1996) 1365-1368
43. Pekkonen E., Rinne T., Reinikainen K., Kujala T., Alho K., and Näätänen R. Aging effects on auditory processing: an event-related potential study. Exp. Aging Res. 22 2 (1996) 171-184
44. Polkey C.E. Alternative surgical procedures to help drug-resistant epilepsy-a review. Epileptic Disord. 5 2 (2003) 63-75
45. Rinne J.O., Tommola J., Laine M., Krause B.J., Schmidt D., Kaasinen V., Teras M., Sipila H., and Sunnari M. The translating brain: cerebral activation patterns during simultaneous interpreting. Neurosci. Lett. 294 2 (2000) 85-88
46. Sackeim H.A., Keilp J.G., Rush A.J., George M.S., Marangell L.B., Dormer J.S., Burt T., Lisanby S.H., Husain M., Cullum C.M., Oliver N., and Zboyan H. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol. Behav. Neurol. 14 1 (2001) 53-62
47. Schachter S.C. Vagus nerve stimulation: mood and cognitive effects. Epilepsy Behav. 5 Suppl. 1 (2004) S56-S59
48. Sinkkonen J., and Tervaniemi M. Towards optimal recording and analysis of the mismatch negativity. Audiol. Neurootol. 5 3/4 (2000) 235-246
49. Sjogren M.J., Hellstrom P.T., Jonsson M.A., Runnerstam M., Silander H.C., and Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J. Clin. Psychiatry 63 11 (2002) 972-980
50. Spanaki M.V., Allen L.S., Mueller W.M., and Morris G.L.R. Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center. Seizure 13 8 (2004) 587-590
51. Uthman B.M., Reichl A.M., Dean J.C., Eisenschenk S., Gilmore R., Reid S., Roper S.N., and Wilder B.J. Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation. Neurology 63 6 (2004) 1124-1126
52. Vonck K., Thadani V., Gilbert K., Dedeurwaerdere S., De Groote L., De Herdt V., Goossens L., Gossiaux F., Achten E., Thiery E., Vingerhoets G., Van Roost D., Caemaert J., De Reuck J., Roberts D., Williamson P., and Boon P. Vagus nerve stimulation for refractory epilepsy: a transatlantic experience. J. Clin. Neurophysiol. 21 4 (2004) 283-289